<?xml version="1.0" encoding="UTF-8"?>
<p id="p0080">Before the first outbreak of SARS, a limited number of HCoVs such as HCoV-229E were frequently found to infect humans, and were widely circulating in human populations causing only mild illnesses like the common cold [
 <xref rid="bib3" ref-type="bibr">3</xref>,
 <xref rid="bib25" ref-type="bibr">25</xref>]. However, SARS, MERS and SARS-CoV-2 present with a spectrum of disease severity ranging from flu-like symptoms to acute respiratory distress syndrome [
 <xref rid="bib25" ref-type="bibr">25</xref>,
 <xref rid="bib26" ref-type="bibr">26</xref>]. Early on, these patients are usually treated with conventional medications which had no clinical benefit, resulting in spread to health care personnel. For those with flu-like symptoms or even more severe disease, it would not be immediately evident that this is an atypical and virulent form of a coronavirus. For comparison, influenza has an estimated mortality rate of 0.07%â€“0.2%. A high index of suspicion is helpful but not foolproof.
</p>
